What substances would still be detectable on a urine drug screen in a patient tested within the last 24 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Detection Window for Substances on Urine Drug Screen

Most substances tested in a standard urine drug screen panel would still be detectable if the patient used them 53-137 hours ago, with the notable exceptions of alcohol (undetectable after 24 hours) and potentially GHB if it was involved (undetectable after 12 hours). 1, 2

Substances Likely Still Detectable (53-137 hours post-use)

Cannabis (Marijuana)

  • Detection window: 2-4 days for single use, up to 1 month for frequent users 3
  • At 53-137 hours (2.2-5.7 days), cannabis would still be detectable in most users, particularly those with any history of regular use 3
  • Cannabis has the longest detection window of all standard panel substances 2

Cocaine

  • Detection window: Up to 1 week for street doses 3
  • At 53-137 hours (2.2-5.7 days), cocaine metabolite (benzoylecgonine) would still be detectable using the standard 300 ng/mL cut-off 3
  • Standard immunoassays target benzoylecgonine, not cocaine itself 3

Amphetamines

  • Detection window: 5 days at 1000 ng/mL cut-off, 6 days at 300 ng/mL cut-off 3
  • At 53-137 hours (2.2-5.7 days), amphetamines would still be detectable within the standard detection window 3

Opiates/Narcotics

  • Detection window: 1-1.5 days for low doses of heroin (3-12 mg), longer for higher doses 3
  • At 53 hours (2.2 days), standard opiates may be at the edge of detectability depending on dose 3
  • At 137 hours (5.7 days), most opiates would likely be undetectable unless very high doses were used 3

Benzodiazepines

  • Detection window: Generally 72 hours or less for most substances 2
  • At 53 hours, benzodiazepines would likely still be detectable 2
  • At 137 hours (5.7 days), most benzodiazepines would be undetectable 2
  • Important caveat: Standard benzodiazepine panels primarily detect oxazepam and may miss clonazepam and lorazepam 2

Buprenorphine

  • Detection window: Generally 72 hours or less 2
  • At 53 hours, buprenorphine would likely still be detectable 2
  • At 137 hours, detectability is uncertain and depends on dose and frequency of use 2

Substances Unlikely to Be Detectable

Alcohol

  • Detection window: Not reliably detected in urine beyond 24 hours 1
  • At 53-137 hours, alcohol would be completely undetectable 1
  • Critical pitfall: Alcohol is not included in many standard drug testing panels despite being the most common substance associated with altered mental status 2

MDMA (Ecstasy)

  • Standard panels frequently do not detect MDMA reliably 2
  • Even if present in the panel, detection window is generally 72 hours or less 2
  • At 137 hours, MDMA would likely be undetectable 2

Critical Clinical Considerations

Timing and Detection Windows

  • With the exception of marijuana, most drugs of abuse have a detection window of 72 hours or less 2
  • The 53-hour timepoint falls within the detection window for most substances 2
  • The 137-hour timepoint (5.7 days) exceeds the detection window for most substances except cannabis 2, 3

Substances Not on Standard Panels

  • Fentanyl requires specific testing and is not detected by standard opiate screens 4
  • Synthetic cannabinoids (K2, Spice) will not be detected on standard cannabinoid screens 2
  • GHB has an extremely short detection window of less than 12 hours and would be undetectable at either timepoint 2
  • Ketamine has a variable detection window of 24-72 hours 2

Important Caveats for Interpretation

  • Immunoassay results should be confirmed with gas chromatography/mass spectrometry (GC/MS) when results will impact clinical decisions 2, 5
  • False-positive rates can be substantial: approximately 14% for amphetamines, 34% for opiates, and 100% for phencyclidine and MDMA 6
  • Dilute urine specimens may cause false-negative results for substances present in low concentrations 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Limitations of Standard Urine Drug Tests

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Detection time of drugs of abuse in urine.

Acta clinica Belgica, 2000

Guideline

Fentanyl Detection on Toxicology Screens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.